Literature DB >> 8634772

Simplified high-performance liquid chromatographic method for the determination of citalopram and desmethylcitalopram in serum without interference from commonly used psychotropic drugs and their metabolites.

O V Olesen1, K Linnet.   

Abstract

A simplified method for the determination of racemic citalopram and its main metabolite desmethylcitalopram in serum using HPLC was developed. The compounds were extracted with heptane-isoamyl alcohol (98:2) and subsequently transferred into phosphate buffer pH 2.5 for direct injection into the HPLC apparatus. The analytes were separated with an acetonitrile-phosphate buffer, pH 2.5-tetraethylamine mobile phase on a C18 column and measured by UV detection at 240 nm. Within the typical range of serum concentrations (30-100 ng/ml) the inter-day variation was < 6% for both compounds. Possible analytical interference from a number of commonly coadministered psychoactive drugs and their metabolites was studied by extracting sera from patients receiving these drugs. Interference was not a problem for the developed method.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634772     DOI: 10.1016/0378-4347(95)00347-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  4 in total

1.  A validated spectrofluorimetric method for the determination of citalopram in bulk and pharmaceutical preparations based on the measurement of the silver nanoparticles-enhanced fluorescence of citalopram/terbium complexes.

Authors:  Muhammad Naeem Khan; Jasmin Shah; Muhammad Rasul Jan; Sang Hak Lee
Journal:  J Fluoresc       Date:  2012-09-27       Impact factor: 2.217

2.  Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment.

Authors:  Marina Mitjans; Alessandro Serretti; Chiara Fabbri; Cristóbal Gastó; Rosa Catalán; Lourdes Fañanás; Bárbara Arias
Journal:  Psychopharmacology (Berl)       Date:  2013-02-14       Impact factor: 4.530

3.  Colorimetric method for the estimation of escitalopram oxalate in tablet dosage form.

Authors:  T Vetrichelvan; K Arul; M Sumithra; B Umadevi
Journal:  Indian J Pharm Sci       Date:  2010-03       Impact factor: 0.975

4.  Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder.

Authors:  Zaiquan Dong; Xiaoling Shen; Yanni Hao; Jin Li; Haizhen Xu; Li Yin; Weihong Kuang
Journal:  Front Neurosci       Date:  2022-07-22       Impact factor: 5.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.